Professional Documents
Culture Documents
ART Treatment 1406failure Interdepartmental Presentation
ART Treatment 1406failure Interdepartmental Presentation
Clinical Pharmacology
Dr A Reid & Dr M Munyoro
Community Medicine
Dr J Chirenda
Community Health Care Nursing
Sr G Mugadza
Outline of Presentation
• Definition of ART failure
• Drivers of ART failure
• Case studies
• Nurse’s Role in ART care
• Public health implications of ART failure
• Question and answer
Reminder
Definition of ART Failure
• Virologic failure is defined as repeated instances of a plasma viral load
≥200 copies/mL after 6 months of therapy. Laboratory results must be
confirmed with repeat testing before a final assessment of virologic
failure is made. (Zim guidelines=>1000copies/mL)
• Immunologic failure refers to a suboptimal immunologic response to
therapy or an immunologic decline while on therapy, but there is no
standardized definition
• Clinical failure refers disease progression despite favourable immunologic
and virologic responses to ART
• https://aidsinfo.nih.gov/guidelines,2019
Viral Load >1,000 copies/ml means
Treatment Failure when…
Viral load >
1000
copies/ml
2 Regimen failure or
consecutive
times treatment failure
indicates possible drug
3 months resistance
apart
With good
the 1,2,3 Rule adherence
in between
4
Goal of ART
A total of 1,150,079 patients receiving ART by Dec, 2018; Majority (78.5%) of ART patients
receiving care at primary care level; 4% on Second line ART and only 202 on Third line ART
Treatment Failure….
11
Case 1: Grace
19 years:
• Deep depression
• Stops ART
• Develops disseminated TB – treated
• Admitted to HDU on Christmas eve with severe pneumonia
12
Case 1: Grace
• Climbs stairs to Clinic Director
• Referral to youth psychiatrist
• Talk therapy and tricylic antidepressant for 6 months
• Out of depression
• Back on ART
• Back to school
• Started “Speed” support group
• Started University studying BSc Social Science
13
Case 2: Patrick
• 45 year old married labourer on 3rd line ART
• October 2016 admitted with treatment failure: severe pneumonia and
CD4 of 80 cells/mm3
• Had defaulted ART for 4 months due to marital discord anger and
depression
• Restarted ART after admission
14
Case 2: Patrick
• June 2017: admitted with Cryptococcal meningitis and CD4 of
2/mm3
• Had defaulted clinic attendance and ART for 6 months
• Anger and depression due to being made redundant leading to
severe food security issues and further marital discord
• Treated, counselled, job back
• Out of depression, food security improved
• Died 6 months later from recurrent Cryptococcal Meningitis
15
Case 3: Tinashe
• 27 year old single unemployed male from rural Seke, vertically
acquired HIV
• Presented with clinical treatment failure and disseminated TB,
CD4 = 68
• Isolated
• Father died when he was 2 years old
• Twin brother died of HIV when he was 14
• Fathered a child by a 17 year old HIV positive girl but she left
him for someone else- “no money “
16
Case 3: Tinashe
18
Case 3 : Tinashe
• Off alcohol now for 18 months
• Viral Load completely suppressed and CD4 count above 120
• Getting involved in leading support groups for teens
19
Cases 1 & 2 & 3
• What do they have in common?
• Psycho-social risk factors causing them to not adhere to
ART
• Multiple losses anger, grief and depression
• Marital discord anger and depression
• Unemployment serious finance and food security issues
anger and depression
• Substance abuse
• Isolation, lack of supports
• Lack of follow-up and retention in care
20
NURSE’S ROLE
Holistic Model of Care for Preventing ART Failure
• Nurses are the first health care providers for the majority of clients/
patients and HIV & AIDS is not exceptional.
• Uses the holistic model of care by looking at the human being is a
complex entity
• Hence the nurse views every client/ patient in his totality if ART treatment is to be
a success.
• Holistic care entails attending to the physical,
Psychological, Spiritual and socioeconomic needs of the
client in order to promote quality of life
ART TREATMENT FAILURE ISSUES
Patient may not ready? – he/she may be non-
adherent
MA
NAG
E
COUNSEL
ASSESSMENT
CLIENT
REFER EDUCATE
FO
LL
O
W
UP
What are the Public Health
Implications of ART Failure?
Goal of ART
Structural
Program
Clinic
Provider
Patient
Viral
Drivers of ARV Resistance
• Largely man-made
• Programmatic
• Patient level
Programmatic Causes
• Erratic supply of antimicrobial agents
• Supply of poor quality antimicrobial agents
• Inadequate monitoring of treatment
• Drug-drug interactions and adverse drug events
• Genetic predisposition
Implications of ART Failure: Costs
Facility type Cost ($)
Primary 116,097
Secondary 300,162
Tertiary 613,558
Quarternary 1,384,125
Source: Prevention of Mother-to-Child Transmission (PMTCT) and And
antiretroviral Treatment (ART) Services Cost evaluation in Zimbabwe report,
2018
Sources of high costs
• New medicines
• Train and re-train health care workers
• Supply chain management
• Prevention of new infections
Prevention and control of ART Failure
• Everyone has a responsibility
• Patient (well described by my colleagues)
• Programmatic (provider)
• Viral
• Non-health sector responsibilities Structural
Program
• Finance
Clinic
• Social Welfare Provider
• Local Government Patient
Viral
Acknowledgements
• Newlands clinic (Dr Chimbetete)
• Dr Choto – MOH
• Dr TD Chawana
• Prof HA Mujuru
Resources
1. Rufu A, Chitimbire VTS, Nzou C, et al. Implementation of the 'Test and Treat'
policy for newly diagnosed people living with HIV in Zimbabwe in 2017. Public
Health Action. 2018;8(3):145–150. doi:10.5588/pha.18.0030
2. Chawana, Tariro & A, Reid & T, Bwakura & Gavi, Samuel & C.F.B, Nhachi.
(2014). Factors Influencing Treatment failure in HIV Positive Adult Patients on
First Line Antiretroviral Therapy. The Central African Journal of Medicine. 60.
3. Chawana, T. D., Katzenstein, D., Nathoo, K., Ngara, B., & Nhachi, C. F. B. (2017).
Evaluating an enhanced adherence intervention among HIV positive adolescents
failing atazanavir/ritonavir-based second line antiretroviral treatment at a public
health clinic. Journal of AIDS and HIV Research, 9(1), 17-30.
4. WHO HIV Drug resistance report 2017
Questions ?